Inappropriate Empiric Therapy as a Driver of Poor Outcomes
JUN 25, 2019 | CONTAGION® EDITORIAL STAFF
Segment Description: Glenn Tillotson, PhD, consultant with GST Micro and Contagion® Editorial Advisory Board member, explains how inappropriate empiric therapy can drive poor outcomes.
Interview transcript (modified slightly for readability):
Dr. Tillotson: "Inappropriate antibiotic empiric therapy is really recognized as a driver of poor outcomes such as longer length of stay in an intensive care unit, a longer length of stay in the hospital alone, prolonged antibiotic therapy, having to swap and change, and, in some skin infections, it actually can lead to mortality. So conditions such as abscesses that are inappropriately treated those can turn into complex challenges."
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512